http://www.druginjuryattorneyblog.com/ Published by Carey, Danis & Lowe en-us 2010-07-29T08:24:32-05:00 http://www.druginjuryattorneyblog.com/2010/07/another_johnson_johnson_drug_m.html Another Johnson & Johnson drug manufacturing plant operated by McNeil has received notice of problems with its manufacturing practices from the FDA. The Lancaster, Pennsylvania plant makes the heartburn and gas relief drugs Pepcid, Imodium and Mylanta. These problems, similar... Dangerous Drugs Carey, Danis & Lowe 2010-07-29T08:24:32-05:00 http://www.druginjuryattorneyblog.com/2010/07/fda_dysfunction_leaves_avandia.html Doctors and patients are worried about whether the diabetes drug Avandia (rosiglitazone) is safe, as I've discussed on several occasions this year from my perspective as a dangerous prescription medication lawyer. Avandia has been associated in several studies with a... Dangerous Drugs Carey, Danis & Lowe 2010-07-21T09:22:22-05:00 http://www.druginjuryattorneyblog.com/2010/07/johnson_johnson_mcneil_drugs_c.html In the last few months I've kept tabs on medications recalled for quality control problems by McNeil Pharmaceuticals, as well as McNeil's parent company Johnson & Johnson's recalls of medications that were "musty-smelling." Unfortunately for consumers who thought their medicine... Dangerous Drugs Carey, Danis & Lowe 2010-07-16T09:14:30-05:00 http://www.druginjuryattorneyblog.com/2010/07/yaz_getting_the_word_out.html The process of getting a pharmaceutical manufacturer to acknowledge the potential dangers of its medicine is long, slow and tedious. After all, the company itself cannot be relied upon to be completely unbiased in the reporting of the medicine it... Carey, Danis & Lowe 2010-07-12T01:44:15-05:00 http://www.druginjuryattorneyblog.com/2010/07/effexor_xr_to_go_generic.html The FDA has just given approval for the extended release (XR) version of the antidepressant Effexor to be produced in a generic formulation. As with all such cases of named medications going generic, this carries benefits and risks. Indeed, the... Carey, Danis & Lowe 2010-07-09T00:39:44-05:00 http://www.druginjuryattorneyblog.com/2010/07/more_evidence_emerges_of_incre.html Diabetics should take note of two newly published studies that confirm existing evidence that the diabetes drug Avandia (rosiglitazone) increases the risk of heart attacks as well as heart failure. As a defective drug injury attorney, I've been closely following... Dangerous Drugs Carey, Danis & Lowe 2010-07-08T09:45:32-05:00 http://www.druginjuryattorneyblog.com/2010/07/paxil_future_cases.html While there are plenty of reasons to celebrate the recent sweeping settlements between Paxil manufacturer Glaxo Smith Kline (GSK) and plaintiffs alleging birth defects caused by the medication, not everything has been entirely put to rest. The news certainly has... Carey, Danis & Lowe 2010-07-07T00:54:33-05:00 http://www.druginjuryattorneyblog.com/2010/07/reglan_no_news.html The modern mass media is a complicated phenomenon, and what predominates is rarely representative of everything going on. For example, right now the news is dominated by events at the G20 summit and the massive oil spill in the Gulf.... Carey, Danis & Lowe 2010-07-04T21:46:17-05:00 http://www.druginjuryattorneyblog.com/2010/07/reglan_the_reason_for_the_case.html Sometimes a look back is the best way to gain perspective. Often the most difficult time when attempting to gain recognition for harm done by a prescription medication is after trouble becomes known, but before that knowledge is widespread. Pharmaceutical... Carey, Danis & Lowe 2010-07-02T01:03:14-05:00 http://www.druginjuryattorneyblog.com/2010/06/yaz_gianvi_labeling_woes.html Gianvi, a repackaged and renamed generic version of Bayer's flagship contraceptive Yaz, is under scrutiny after its parent company admitted to inappropriate labeling practices. According to Bayer, the company marketing Gianvi has admitted that it falsely labeled the generic medication.... Carey, Danis & Lowe 2010-06-30T00:39:42-05:00